Company Orgenesis Inc Other OTC

Equities

US68619K1051

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Medical Equipment, Supplies & Distribution

Inactive Instrument

Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Companyâs therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomeraâs services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

USD in Million	2022	Weight	2023	Weight	Delta
Therapies 97.2 %	6	17.9 %	1	97.2 %	-91.99%
Octomera 12.8 %	35	97.6 %	0	12.8 %	-99.81%
Eliminations -10.0 %	-6	-15.5 %	0	-10.0 %	-99.05%

USD in Million	2022	Weight	2023	Weight	Delta
Belgium 100.0 %	36	100.0 %	1	100.0 %	-98.53%

Managers	Title	Age	Since
Sarah Ferber FOU	Founder	70	04/06/08
Vered Caplan CEO	Chief Executive Officer	55	01/02/12
Victor Miller DFI	Director of Finance/CFO	54	01-01
Heiko von der Leyen CTO	Chief Tech/Sci/R&D Officer	-	31/08/20
Gerhard Bauer PRN	Corporate Officer/Principal	-	05/09/23

Members of the board	Title	Age	Since
David Sidransky BRD	Director/Board Member	64	17/07/13
Vered Caplan CEO	Chief Executive Officer	55	01/02/12
Mario Philips BRD	Director/Board Member	54	08/01/20
Yaron Adler BRD	Director/Board Member	54	16/04/12
Guy Yachin BRD	Director/Board Member	55	01/04/12
Ashish Nanda BRD	Director/Board Member	59	21/02/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	34,666,847	24,404,393 ( 70.40 %)	286,567 ( 0.8266 %)	70.40 %

Name	Equities	%	Valuation
Jacob Safier 14.53 %	4,988,000	14.53 %	3 M $
Vanguard Global Advisers LLC 2.694 %	925,113	2.694 %	466 257 $
Knoll Capital Management LP 1.848 %	634,738	1.848 %	319 908 $
Geode Capital Management LLC 0.8386 %	287,955	0.8386 %	145 129 $
Vered Caplan 0.8101 %	278,191	0.8101 %	140 208 $
BlackRock Institutional Trust Co. NA 0.3529 %	121,185	0.3529 %	61 077 $
STATE STREET CORPORATION 0.2582 %	88,659	0.2582 %	44 684 $
Yaron Adler 0.1844 %	63,304	0.1844 %	31 905 $
Northern Trust Investments, Inc.(Investment Management) 0.1184 %	40,673	0.1184 %	20 499 $
Renaissance Technologies LLC 0.1008 %	34,599	0.1008 %	17 438 $

Orgenesis, Inc.

20271 Goldenrod Lane

20876, Germantown

+480 659 6404

http://www.orgenesis.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-5.51%	181B
MEDTRONIC PLC	+2.33%	112B
BECTON, DICKINSON AND COMPANY	-3.62%	67.92B
DEXCOM, INC.	+1.52%	50.1B
CENCORA, INC.	+8.06%	44.27B
HOYA CORPORATION	+9.39%	40.41B
METTLER-TOLEDO INTERNATIONAL, INC.	+23.35%	31.95B
WEST PHARMACEUTICAL SERVICES, INC.	+0.67%	25.82B
TERUMO CORPORATION	+17.27%	25.29B

Other Medical Equipment, Supplies & Distribution